惠誉国际：中国医疗保健数字化快速发展

▲全球视野 本土思考

中国的此类试验数量猛增了七倍，达到135次。

中国已保证推进在线诊断和治疗的发展。

惠誉资询的一份报告显示，为缓解当前的痛点并为未来的流行做好准备，预计中国医疗保健系统的数字化将迅速发展。

惠誉指出，电子记录，数字处方和其他IT基础设施将系统地跟踪和分析大量患者数据，而AI和大数据将最终帮助医院重新分配稀缺资源并提高诊断准确性。

当局还承诺促进在线诊断和治疗以及基于互联网的医院的发展，这有望缓解线下医疗机构的压力，并有助于预防和控制疫情。

预计中国将继续受益于创新制药行业的大量投资。

报告称：“尽管中国药品市场在药品定价和知识产权保护水平较低的挑战下仍面临不确定性，但我们仍认为中国市场是亚太地区最具吸引力的投资目的地之一”。

预计中国的医疗保健系统将实现更大程度的技术整合，这将有助于解决该国医疗资源地理分布不均的问题。

该报告指出，与地方社区医疗保健中心相比，中国的医生继续集中在省会城市–限制了农村地区的医疗保健获取。

惠誉补充道：“此外，中国的医疗体系还为医生短缺而努力，工资低廉，缺乏当地诊所和全科医生也加剧了这一状况。在中国，每千人只有1.5名医生，而美国每千人只有2.5名医生”。

这场大流行还推动了中国医疗保健行业的数字化转型和创新。该行业已采用了新一代数字技术，包括云计算，大数据和人工智能。

2019年，中国医药市场价值估计为149.7b美元（CNY1.03t），比上年增长5.5％。到2020年，市场预计将增长3.2％至$ 149.37b（CNY1.07t）。＊

China's healthcare digitalisation to rapidly advance: Fitch

Authorities have pledged to advance the development of online diagnosis and treatment.

To relieve current pain points and prepare for future epidemics, the digitalisation of China's healthcare system is expected to rapidly advance, according to a report from Fitch Solutions.

Electronic records, digital prescriptions and other IT infrastructure will systematically track and analyse extensive patient data, whilst AI and big data will eventually help hospitals reallocate scarce resources and improve diagnosis accuracy, Fitch noted.

The authorities have also pledged to advance the development of online diagnosis and treatment as well as internet-based hospitals, which is expected to help ease the pressure on medical institutions offline and contribute to outbreak prevention and control.

China is expected to continue benefitting from significant investment from the innovative pharma industry.

"Whilst the Chinese pharmaceutical market continues to face uncertainty on the back of challenges around drug pricing and the low levels of intellectual property protection, we maintain our view that it presents one of the most attractive investment destinations in the Asia Pacific region," the report stated.

China’s healthcare system is also expected to see a greater integration of technology, which can help address the uneven geographic distribution of medical resources in the country.

The report noted that doctors in China continue to be concentrated in provincial capitals as compared to local level community healthcare centres – limiting healthcare access in the rural regions.

"Moreover, China’s healthcare system also grapples with a shortage of doctors, exacerbated by low wages and a lack of local clinics and general practitioners. In the country, there are only 1.5 doctors for every 1,000 people, compared with 2.5 for every 1,000 in the US," Fitch added.

The pandemic has also prompted the digital transformation and innovation in China's healthcare industry. The industry has adopted a new generation of digital technologies, including cloud computing, big data and artificial intelligence.

In 2019, China's pharmaceutical market is estimated to be valued at $149.7b (CNY1.03t), climbing 5.5% from the previous year. In 2020, the market is projected to grow 3.2% to $149.37b (CNY1.07t).